Onconic Therapeutics Inc.
476060
企业摘要
季度业绩走势
营业收入
营业利润率
市场偏好度
※ 点击图表可查看该月份的AI分析信息。
营业收入
合并
单独
营业利润
合并
单独
净利润
合并
单独
财务信息
保存为Excel
该期间没有财务信息数据。
~
季度
决算
*单位基准小数点第四位以下的数值标记为'0/-0'
财务指标预测
※ 本预测值是基于历史数据的AI简单估算值，可能与实际业绩存在差异。
企业概况
截至2026年6月
Onconic Therapeutics Inc. researches and develops globally innovative new drugs in the fields of acid-induced digestive diseases and oncology, which have large unmet medical needs. The company focuses on researching and developing small-molecule-based new drugs, which have relatively lower development and commercialization costs compared to biologic new drugs and can supply patients suffering from disease with reasonably priced new treatments, and it has unrivaled technology and R&D capabilities in small-molecule synthetic new drugs in the digestive disease and synthetic lethality oncology fields, which have large unmet medical needs in the market.
代表理事
Kim Jon
成立日期
2020年5月7日
法人类型
韩国创业板
行业分类
Research and experimental development on natural sciences and engineering
法人注册号
11011-7478088
营业执照号
268-86-01778
电话号码
02-3454-0780
传真号码
02-3454-0784
公司地址
12 Teheran-ro 26-gil, Gangnam-gu, Seoul
产品与服务
评论